Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Healthcare Advertising Agencies
Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Mydecine Innovations Group Inc
Bullboard Posts
User Avatar Image
(3)
•••
Comment by kevin2m4on Oct 30, 2017 12:53pm
56 Views
Post# 26876928

RE:RE:RE:RE:RE:RE:RE:RE:anyone get their NHS shares?

RE:RE:RE:RE:RE:RE:RE:RE:anyone get their NHS shares?

Hi Kevin,
Thanks for contacting Questrade.  My name is Najib and I’ll be happy to help you.
Whenever there is a corporate action such as a merger or split, we can only update your position as soon as the underlying company provides us the new shares. As soon as we receive the new shares, you will be able to trade them automatically. Usually the timeframe is 3 -10 business days.
Please login to myQuestrade. Then go to " Requests" -> "Corporate Actions".  You will then be able to indicate your preference on this screen.
Please note that due to security reasons, we are not able to discuss your account history over email. However, we can securely review this if you contact us via live chat, or you may contact us by phone.
Questions? Chat online or call us at 1.888.783.7866. We’re available Monday to Friday, 7:30 am to 8 pm ET. You can also email support@questrade.com.
Thanks,
Najib
Client Services Specialist
 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities